Super Power: Recall - Undeclared Ingredient
Finished product of Super Power was tested and found to contain trace amounts of sildenafil.
Undefined
Finished product of Super Power was tested and found to contain trace amounts of sildenafil.
Large clinical trial findings of significant elevations of both ALT and bilirubin.
Some disposable cannulas provided may leak viscoelastic material or detach from the syringe during injection. In rare incidences, detachment has resulted in serious patient injury.
L’Agenzia Italiana del Farmaco rende disponibili on line nuove ed importanti informazioni sulla sospensione del trattamento con TREDAPTIVE/TREVACLYN/PELZONT (acido nicotinico/laropiprant).
Serious adverse events may include impaired alertness, drowsiness, confusion, low blood pressure, coma, and respiratory depression.
Il Comitato per i Medicinali per
Uso Umano (CHMP) dell'Agenzia Europea dei Medicinali ha confermato la
raccomandazione di sospendere l’autorizzazione all’immissione in commercio di
Tredaptive, Pelzont e Trevaclyn (acido nicotinico / laropiprant) usati per il
trattamento di pazienti adulti con dislipidemia (livelli ematici anormalmente
elevati di grassi quali trigliceridi e
colesterolo).
Metal release will cause some tiny metal particles to wear off of the device around the implant, which may cause damage to bone and/or soft tissue surrounding the implant and joint.
80.211.154.110